← Back
▼ SELL 10b5-1 Plan

$ Value

$84K

Shares

602

Price

$139

Filed

Jul 22

Insider

Name

Brophy Michael Burkes

Title

CHIEF FINANCIAL OFFICER

CIK

0001697362

Roles

Officer

Transaction Details

Transaction Date

2025-07-21

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

71,414

Footnotes

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. | The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 28, 2022. | The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.

Filing Info

Accession No.

0001415889-25-020160

Form Type

4

Issuer CIK

0001604821

Brophy Michael Burkes's History

Date Ticker Type Value
2026-03-10 NTRA $160K
2026-03-09 NTRA A
2026-02-27 NTRA A
2026-02-03 NTRA $293K
2026-02-03 NTRA $158K
2026-02-03 NTRA $1.1M
2026-01-29 NTRA $228K
2026-01-29 NTRA $202K
2026-01-28 NTRA $294K
2026-01-28 NTRA $279K

Other Insiders at NTRA (90d)

Insider Bought Sold Last
BOTHA ROELOF 2026-01-30
ROSENMAN HERM 2026-01-30
Williams Brinkley Ruth 2026-01-30
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
$38.3M 2026-04-06
Sheena Jonathan $2.4M 2026-04-17
Baynes Roy D. 2026-01-30
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
$2.9M 2026-03-10
Marcus Gail Boxer 2026-01-30
Chapman Steven Leonard
CEO AND PRESIDENT
$24.1M 2026-03-10
Bertagnolli Monica 2026-01-30
Chapman Rowan E $23K 2026-03-13
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
$4.5M 2026-04-01
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
$3.0M 2026-04-01
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
$1.4M 2026-03-10